Steady-state murine cDCs employ a number of mechanisms to limit viral infection, including constitutive basal expression of antiviral IFITM1/3 (90) and high level of expression of the thioesterase, PPT1, which protects steady state DCs from viral infection by promoting antigen degradation (112). Here, PPT1 is linked to viral infectious disease.